ROCHESTER, N.Y., Feb. 10 — Joseph F. Ruh has been appointed General Counsel and Corporate Secretary at Carestream Health effective immediately. In this role, he will lead the company’s worldwide legal organization and is a member of the company’s senior executive leadership team.

Advanced Integration delivers synchronized formulary management to the operating room to increase medication safety and security.

More than a dozen pay-for-publish open access medical journals accepted a hoax article studying the “neoplastic role of cacao extract in breakfast cereals.”

Intelerad’s industry-leading medical solutions now available through GSA Advantage!® website.

Edward Singleton, MD, the first physician hired at Houston’s Texas Children’s Hospital in 1952 died Jan. 10 at the age of 94.

Fort Lee, New Jersey, January 8, 2015 – Rayence Inc. announced the appointment of Bill Cioffi as Vice President of Business Development. Cioffi, an industry veteran who spent the majority of 35 year career in management positions at Fujifilm Medical Systems and later Del Medical, joined Rayence in mid-2014 as Director of Sales and Marketing.

Papworth Hospital NHS Foundation Trust has officially unveiled a SOMATOM® Force in its Radiology Department to bolster its cardiac imaging services. The new technology was launched by Cambridge MP Dr Julian Huppert at the official opening of the system. The CT imaging system will benefit patients by using the lowest achievable dose and provide patients who suffer with shortness of breath with rapid scanning. With approximately half of all the hospital’s CT imaging consisting of cardiac procedures, it is anticipated the system will increase cardiac throughput.

FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas biosciences industry as a center for world-class development and manufacturing of life-saving biopharmaceuticals and biotechnology while providing FUJIFILM Diosynth Biotechnologies with expanded capacity for its growing vaccine capabilities. The completion of the previously announced Purchase Interest Agreement of Kalon Biotherapeutics, LLC, was made with the owners of Kalon: the State of Texas, acting by and through the Office of the Governor, and The Texas A&M University System. The announcement was made jointly today by Governor Rick Perry; officials of FUJIFILM Corporation, FDBU and Mitsubishi Corporation; Kalon Biotherapeutics LLC; and the Texas A&M System. Going forward, the company is now known as FUJIFILM Diosynth Biotechnologies Texas, LLC.